Subcutaneous Panniculitis-Like T-Cell Lymphoma in a 2-Year-Old: Case Report and Literature Review.

IF 1 4区医学 Q4 DERMATOLOGY

American Journal of Dermatopathology Pub Date : 2025-10-01 Epub Date: 2025-07-21 DOI:10.1097/DAD.0000000000003070

Clara Ureña-Paniego, Francisco Vílchez-Márquez, María Narváez-Simón, Elena Masana-Flores, Salvador Arias-Santiago

引用次数: 0

Abstract

Abstract: Subcutaneous panniculitis-like T-cell lymphoma is a rare cutaneous T-cell lymphoma characterized by cytotoxic T-cell infiltration of subcutaneous fat that clinically mimics panniculitis. It predominantly affects adults and is rarely present in young children. We report a case of subcutaneous panniculitis-like T-cell lymphoma in a 2-year-old child and review the pediatric literature to highlight the unique clinical features and outcomes in this age group.

查看原文本刊更多论文

2岁皮下泛膜炎样t细胞淋巴瘤病例报告及文献复习。

摘要：皮下潘膜炎样t细胞淋巴瘤是一种罕见的皮肤t细胞淋巴瘤，临床表现为细胞毒性t细胞浸润皮下脂肪，类似潘膜炎。它主要影响成人，很少出现在幼儿身上。我们报告一例2岁儿童皮下pannicitis样t细胞淋巴瘤，并回顾儿科文献以强调该年龄组独特的临床特征和结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Dermatopathology 医学-皮肤病学

CiteScore

1.80

自引率

9.10%

发文量

453

审稿时长

3 months

期刊介绍： The American Journal of Dermatopathology offers outstanding coverage of the latest diagnostic approaches and laboratory techniques, as well as insights into contemporary social, legal, and ethical concerns. Each issue features review articles on clinical, technical, and basic science advances and illuminating, detailed case reports. With the The American Journal of Dermatopathology you''ll be able to: -Incorporate step-by-step coverage of new or difficult-to-diagnose conditions from their earliest histopathologic signs to confirmatory immunohistochemical and molecular studies. -Apply the latest basic science findings and clinical approaches to your work right away. -Tap into the skills and expertise of your peers and colleagues the world over peer-reviewed original articles, "Extraordinary cases reports", coverage of practical guidelines, and graphic presentations. -Expand your horizons through the Journal''s idea-generating forum for debating controversial issues and learning from preeminent researchers and clinicians